SAGE-904

· Supernus Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SAGE-904, covering 2025-09-17 to 2025-09-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants [Phase 1]

See pricing